Cargando…
Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304773/ https://www.ncbi.nlm.nih.gov/pubmed/30583726 http://dx.doi.org/10.1186/s12885-018-5215-7 |
| _version_ | 1783382429837295616 |
|---|---|
| author | Tan, Wan-Ling Ng, Quan Sing Lim, Cindy Tan, Eng Huat Toh, Chee Keong Ang, Mei-Kim Kanesvaran, Ravindran Jain, Amit Tan, Daniel S. W. Lim, Darren Wan-Teck |
| author_facet | Tan, Wan-Ling Ng, Quan Sing Lim, Cindy Tan, Eng Huat Toh, Chee Keong Ang, Mei-Kim Kanesvaran, Ravindran Jain, Amit Tan, Daniel S. W. Lim, Darren Wan-Teck |
| author_sort | Tan, Wan-Ling |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6304773 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63047732019-01-02 Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases Tan, Wan-Ling Ng, Quan Sing Lim, Cindy Tan, Eng Huat Toh, Chee Keong Ang, Mei-Kim Kanesvaran, Ravindran Jain, Amit Tan, Daniel S. W. Lim, Darren Wan-Teck BMC Cancer Correction BioMed Central 2018-12-24 /pmc/articles/PMC6304773/ /pubmed/30583726 http://dx.doi.org/10.1186/s12885-018-5215-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Correction Tan, Wan-Ling Ng, Quan Sing Lim, Cindy Tan, Eng Huat Toh, Chee Keong Ang, Mei-Kim Kanesvaran, Ravindran Jain, Amit Tan, Daniel S. W. Lim, Darren Wan-Teck Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases |
| title | Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases |
| title_full | Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases |
| title_fullStr | Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases |
| title_full_unstemmed | Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases |
| title_short | Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases |
| title_sort | correction to: influence of afatinib dose on outcomes of advanced egfr-mutant nsclc patients with brain metastases |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304773/ https://www.ncbi.nlm.nih.gov/pubmed/30583726 http://dx.doi.org/10.1186/s12885-018-5215-7 |
| work_keys_str_mv | AT tanwanling correctiontoinfluenceofafatinibdoseonoutcomesofadvancedegfrmutantnsclcpatientswithbrainmetastases AT ngquansing correctiontoinfluenceofafatinibdoseonoutcomesofadvancedegfrmutantnsclcpatientswithbrainmetastases AT limcindy correctiontoinfluenceofafatinibdoseonoutcomesofadvancedegfrmutantnsclcpatientswithbrainmetastases AT tanenghuat correctiontoinfluenceofafatinibdoseonoutcomesofadvancedegfrmutantnsclcpatientswithbrainmetastases AT tohcheekeong correctiontoinfluenceofafatinibdoseonoutcomesofadvancedegfrmutantnsclcpatientswithbrainmetastases AT angmeikim correctiontoinfluenceofafatinibdoseonoutcomesofadvancedegfrmutantnsclcpatientswithbrainmetastases AT kanesvaranravindran correctiontoinfluenceofafatinibdoseonoutcomesofadvancedegfrmutantnsclcpatientswithbrainmetastases AT jainamit correctiontoinfluenceofafatinibdoseonoutcomesofadvancedegfrmutantnsclcpatientswithbrainmetastases AT tandanielsw correctiontoinfluenceofafatinibdoseonoutcomesofadvancedegfrmutantnsclcpatientswithbrainmetastases AT limdarrenwanteck correctiontoinfluenceofafatinibdoseonoutcomesofadvancedegfrmutantnsclcpatientswithbrainmetastases |